Limitations, agreements, and source contact

UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment · Source last updated 2021-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

point Of Contact

email

MZangari@uams.edu

organization

University of Arkansas for Medical Sciences

phone

501-686-8274

title

Maurizio Zangari, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice